Zimmer Biomet Increases Share Repurchase Expectations to $1 Billion

Zimmer Biomet Holdings, Inc. has announced an increase in its share repurchase expectations for fiscal year 2026, now anticipating to buy back up to $1 billion of its common stock. This marks a $250 million increase from prior estimates. The repurchase will be conducted under a $1.5 billion authorized program approved in February 2026. The company has emphasized that the timing and amount of the repurchases will depend on various factors such as market conditions and stock price.